You just read:

DelMar Pharmaceuticals Presents Poster at AACR's Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer

News provided by

DelMar Pharmaceuticals, Inc.

Oct 03, 2017, 05:30 ET